B19 Parvovirus and autoimmune diseases;Parvovirus B19 et maladies auto-immunes

Revue du Rhumatisme (Edition Francaise)

Volumn 70, Issue 1, 2003, Pages 9-15

  Meyer, Olivier ^a  

^a BICHAT HOSPITAL   (France)

Author keywords

B19 parvovirus; Polyarthritis; Rheumatoid arthritis; Systemic lupus erythematosus; Vasculitis

Indexed keywords

ANTINUCLEAR ANTIBODY; DNA ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; LA ANTIBODY; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; RO ANTIBODY; VIRUS ANTIBODY; VIRUS DNA;

ALLELE; ANAPHYLACTOID PURPURA; ANTIBODY PRODUCTION; APLASTIC ANEMIA; ARTHRALGIA; ARTHROPATHY; AUTOIMMUNE DISEASE; BLOOD CELL; BLOOD VESSEL; CHEEK; CYTOPENIA; DISEASE COURSE; ERYTHEMA INFECTIOSUM; FETUS HYDROPS; FOOT; GIANT CELL ARTERITIS; HAND; HEMOLYTIC ANEMIA; HISTOCOMPATIBILITY GENE; HUMAN; IMMUNOGLOBULIN PRODUCTION; PARVOVIRUS; POLYARTERITIS NODOSA; POLYARTHRITIS; POLYMERASE CHAIN REACTION; RASH; REVIEW; RHEUMATOID ARTHRITIS; SERODIAGNOSIS; SEROLOGY; SYNOVIUM; SYSTEMIC LUPUS ERYTHEMATOSUS; VASCULITIS; VIRUS INFECTION; VIRUS MORPHOLOGY; WEGENER GRANULOMATOSIS;

EID: 11244320648     PISSN: 11698330     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1169-8330(02)00004-2     Document Type: Review

References (69)

1. Morinet F, Tchernia G. Le parvovirus B19 et l'hématopoï èse. Medecine-Sciences 1991;7:127-37.
2. Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000;1:289-94.
3. Naides SJ. Rheumatic manifestations of parvovirus B19 infection. Rheum Dis Clin North Am 1998;24:375-401.
4. Karmochkine M. Infection humaine par le parvovirus B19, Mise au point. Rev Med Int 1995;16:905-12.
5. Labau E, Bonnet E, Alric L, Massip P. Infection par le parvovirus B19, Nouvelles approches physiopathologiques. Presse Med 1996;25:162-6.
6. Smith CA, Woolf AD, Lenci M. Parvoviruses: infections and arthropathies. Rheum Dis Clin North America 1987;13:249-63.
7. Wendling D, Lorge JF, Kremer P. Les manifestations rhumatologiques de l'infection à parvovirus B19. Press Med 1995;24:233-6.
8. Woolf AD, Campion GV, Chishick A, Wise S, Cohen BJ, Klouda PT, et al. Clinical manifestations of human parvovirus B19 in adults. Arch Int Med 1989;149:1153-6.
9. Weinberg JM, Wolfe JT, Frattali AL, Werth VP, Naides SJ, Spiers EM. Parvovirus B19 infection associated with acute hepatitis, arthralgias, and rash. J Clin Rheumatol 1996;2:85-8.
10. Naides SJ, Scharosch LL, Foto F, Howard EJ. Rheumatologic manifestations of human parvovirus B19 infection in adults, Initial two-year clinical experience. Arthritis Rheum 1990;33:1297-309.
11. White DG, Woolf AD, Mortimer PP, Cohen BJ, Blake DR, Bacon PA. Human parvovirus arthropathy. Lancet 1985;1:419-21.
12. Klouda PT, Corbin SA, Bradley AA, Cohen BJ, Woolf AD. HLA and acute arthritis following human parvovirus infection. Tissue Antigens 1989;28:318-9.
13. Woolf AD, Campion GV, Klouda P, Chiswick A, Cohen B, et al. HLA and the clinical manifestations of human parvovirus infection. Brit J Rheumatol 1986;25(suppl 2):35.
14. Kerr JR, Boyd N. Autoantibodies following parvovirus B19 infection. J Infect 1996;32:41-7.
15. Soloninka CA, Anderson MJ, Laskin CA. Anti-DNA and antilymphocyte antibodies during acute infection with human parvovirus B19. J Rheum 1989;16:777-81.
16. Loisou S, Cazabon JK, Walport MJ, Tait D, So AK. Similarities of specificity and cofactor dependence in serum antiphospholipid antibodies from patients with human parvovirus B19 infection and from those with systemic lupus erythematosus. Arthritis Rheum 1997;40:103-8.
17. Johnston AM, Hill K, Wookcock BE. Lupus anticoagulant in a patient with parvovirus B19 infection. Clin Lal Haematol 2000;22:109-10.
18. Lunardi C, Tiso M, Borgato L, Nanni L, Millo R, De Sandre G, et al. Chronic parvovirus B19 infection induces the production of anti-virus antibodies with autoantigen binding properties. Eur J Immunol 1998;28:936-48.
19. Altschuler EL. Parvovirus B19 and the pathogenesis of rheumatoid arthritis: a case for historical reasoning. Lancet 1999;354:1026-7.
20. Takahashi Y, Murai C, Shibata S, Munakata Y, Ishii T, Ishii K, et al. Human parvovirus B19 as a causative agent for rheumatoid arthritis. Proc Natl Acad Sci USA 1998;95:8227-32.
21. Ray NB, Nieva DCR, Seftor EA, Khalkhali-Ellis Z, Naides SJ. Induction of an invasive phenotype by human parvovirus B19 in normal human synovial fibroblasts. Arthritis Rheum 2001;44:1582-6.
22. Jones LP, Erdman DD, Anderson LJ. Prevalence of antibodies to human parvovirus B19 nonstructural protein in persons with various clinical outcomes following B19 infection. J Infect Dis 1999;180:500-4.
23. Nikkari S, Roivainen A, Hannonen P, Möttönen T, Luukkainen R, Yli-Jama T, et al. Persistence of parvovirus B19 in synovial sluid and bone marrow. Ann Rheum Dis 1995;54:597-600.
24. Murai C, Munakata Y, Takahashi Y, Ishii T, Shibata S, Muryoi T, et al. Rheumatoid arthritis after human parvovirus B19 infection. Ann Rheum Dis 1999;58:130-2.
25. Kerr JR, Coyle PV, DeLeys RJ, Patterson CC. Follow-up study of clinical and immunological findings in patients presenting with acute parvovirus B19 infection. J Med Virol 1996;48:68-75.
26. Stahl HD, Pfeiffer R, Von Salis-Soglio G, Emmrich F. Parvovirus B19 associated mono and oligoarticular arthritis may evolve into a chronic inflammatory arthropathy fulfilling criteria for rheumatoid arthritis or spondylarthropathy. Clin Rheumatol 2000;19:510-1.
27. Gran JT, Johnsen V, Myklebust G, Nordbo SA. The variable clinical picture of arthritis induced by human parvovirus B19, A report of seven adult cases and review of the literature. Scand J Rheumatol 1995;24:174-9.
28. Kerr JR, Ferguson WP, McMillan SA, Bruce LN, Bell AL. Parvovirus B19 and acute joint swelling in rheumatoid arthritis patients. An Rheum Dis 1996;55:648-9.
29. Harrison B, Silman A, Barrett E, Symmons D. Low frequency of recent parvovirus infection in a population-based cohort of patients with early inflammatory polyarthritis. Ann Rheum Dis 1998;57:375-7.
30. Kerr JR, Cartron JP, Curran MD, Moore JE, Elliott JRM, Mollan RAB. A study of the role of parvovirus B19 in rheumatoid arthritis. Brit J Rheumatol 1995;34:809-13.
31. Cassinotti P, Siegl G, Michel BA, Bruhlmann P. Presence and significance of human parvovirus B19 DNA in synovial membranes and bone marrow from patients with arthritis of unknown origin. J Med Virol 1998;56:199-204.
32. Stahl HD, Hubner B, Seidl B, Liebert UG, van der Heijden IM, Wilbrink B, et al. Detection of multiple viral DANN species in synovial tissue and fluid of patients with early arthritis. Ann Rheum Dis 2000;59:342-6.
33. Nikkari S, Luukkainen R, Mottonen T, Meurman O, Hannonen P, Skurnik M, et al. Does parvovirus B19 have a role in rheumatoid arthritis?. Ann Rheum Dis 1994;53:106-11.
34. Saal JG, Steidle M, Einsele H, Müller CA, Fritz P, Zacher J. Persistence of B19 parvovirus in synovial membranes of patients with rheumatoid arthritis. Rheumatol Int 1992;12:147-51.
35. Morey AL, Ferguson DJ, Fleming KA. Ultrastructural features of of fetal erythroid precursors infected with parvovirus B19 in vitro: evidence of cell death by apoptosis. J Pathol 1993;169:213-20.
36. Meyer O, Ribard P, Belmatoug N, Kahn MF, Grossin M, Fournet JC, et al. Trois cas de lymphadénite de Kikuchi au cours du lupus érythémateux systémique. Ann Med Int 1991;142:259-64.
37. Fawaz-Estrup F. Human parvovirus infection: rheumatic manifestations, angioedema, C1 esterase inhibitor deficiency, ANA positivity, and possible onset of systemic lupus erythematosus. J Rheumatol 1996;23:1180-5.
38. Dubost JJ, Thevenet JP, Peigue-Lafeuille H, Sauvezie B, Rampon S. Arthrite aiguë à parvovirus B19. Press Med 1987;16:399-400.
39. Moore TL, Bandlamudi R, Alam SM, Nesher G. Parvovirus infection mimicking systemic lupus erythematosus in a pediatric population. Sem Arthritis Rheum 1999;28:314-8.
40. Trapani S, Ermini M, Falcini F. Human parvovirus B19 infection: its relationship with systemic lupus erythematosus. Semin Arthritis Rheum 1999;28:319-25.
41. Tanaka A, Sugawara A, Sawai K, Kuwahara T. Human parvovirus B19 infection resembling systemic lupus erythematosus. Intern Med 1998;37:708-10.
42. Meyer O, Kahn MF, Grossin M, Ribard P, Belmatoug N, Morinet F, et al. Parvovirus B19 infection can induce histiocytic necrotizing lymphadenitis (Kikuchi's disease) associated with systemic lupus erythematosus. Lupus 1991;1:37-41.
43. Chassagne P, Mejjad O, Gourmelen O, Moore N, Le Loet X, Deshayes P. Exacerbation of systemic lupus erythematosus during human parvovirus B19 infection. Brit J Rheumatol 1993;32:158-9.
44. Hemauer A, Beckenlehner K, Wolf H, Lang B, Modrow S. Acute parvovirus B19 infection in connection with a flare of systtemmic lupus erythematodes in a female patient. J Clin Virol 1999;14:73-8.
45. Hsu TC, Tsay GJ. Human parvovirus B19 infection in patients with systemic lupus erythematosus. Rheumatol 2001;40:152-7.
46. Bengtsson A, Widell A, Elmstahl S, Sturfelt G. No serological indications that systemic lupus erythematosus is linked with exposure to human parvovirus B19. Ann Rheumatol Dis 2000;59:64-6.
47. Bilidi M, Gatfosse M, Barjonet G. Adult onset Still disease associated with acute parvovirus B19 infection in pregnancy. Ann Med Int 1996;147:518-9.
48. Pouchot J, Ouakil H, Debin ML, Vinceneux P. Adult Still's disease associated with acute human parvovirus B19 infection. Lancet 1993;341:1280-1.
49. Godeau B, Palazzo E, Morinet F, Delplanche M, Deforge L, Schaeffer A, et al. Is Still's disease associated with parvovirus B19 infection? Lancet 1994;345:59-60.
50. Lewkonia RM, Horne D, Dawood MR. Juvenile dermatomyositis in a child infected with human parvovirus B19. Clin Infect Dis 1995;21:430-2.
51. Chevrel G, Calvet A, Belin V, Miossec P. Dermatomyositis associated with the presence of parvovirus B19 DNA in muscle. Rheumatology 2000;39:1037-9.
52. Crowson AN, Magro CM, Dawood MR. A causal role for parvovirus B19 infection in adult dermatomyositis and other autoimmune syndromes. J Cutan Pathol 2000;27:505-15.
53. Ramos-Casals M, Cervera R, Garcia-Carrasco M, Vidal J, Trejo O, Jimenez S, et al. Cytopenia and past human parvovirus B19 infection in patients with primary Sjögren's syndrome. Semin Arthritis Rheum 2000;29:373-8.
54. Ferri C, Zakrzewska K, Longombardo G, Giuggioli D, Storino FA, Pasero G, et al. Parvovirus B19 infection of bone marrow in systemic sclerosis patients. Clin Exp Rheumatol 1999;17:715-20.
55. Hemauer A, Modrow S, Georgi J, Helmke K, Vaith P, Lang B, et al. There is no association between polymyalgia rheumatica and acute parvovirus B19 infection. Ann Rheum Dis 1999;58:657.
56. Gabriel SE, Espy M, Erdman DD, Bjornsson J, Smith TF, Hunder GG. The role of pavovirus B19 in the pathogenesis of giant cell arteritis, A preliminary evaluation. Arthritis Rheum 1999;42:1255-8.
57. Chakravarty K, Merry P. Systemic vasculitis and atypical infections: report of two cases. Postgrad Med J 1999;75:544-6.
58. Diaz F, Collazos J. Glomerulonephritis and Henoch-Schoenlein purpura associated with acute parvovirus B19 infection. Clin Nephrol 2000;53:237-8.
59. Quemeneur T, Lambert M, Fauchais AL, Queyrel V, Michon-Pasturel U, Hachulla E, et al. Purpura rhumatoïde de l'adulte et infection à parvovirus B19 : association fortuite ou vascularite induite par le parvovirus B19? Rev Med Int 2002;23:77-80.
60. Finkel TH, Torok TJ, Fergusson PJ, Durigon EL, Zaki SR, Leung DY, et al. Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent? Lancet 1994;343:1255-8.
61. Nikkari S, Mertsola J, Korvenranta H, Vainionpaa R, Toivanen P. Wegener's granulomatosis and parvovirus B19 infection. Arthritis Rheum 1994;37:1707-8.
62. Cacoub P, Boukli N, Hausfater P, Garbarg-Cheon A, Ghillani P, Thibault V, et al. Parvovirus B19 infection, hepatitis C virus infection and mixed cryoglobulinaemia. Ann Rheum Dis 1998;57:422-4.
63. Corman LC, Dolson DJ. Polyarteritis nodosa and parvovirus B19 infection. Lancet 1992;339:491.
64. Gaches F, Loustaud V, Vidal E, Delaire L, Guiard-Schmid JB, Lavoine E, et al. Periarteritis nodosa and parvovirus B19 infection. Rev Med Int 1993;14:323-5.
65. Nigro G, Zerbini M, Krzysztofiak A, Gentilomi G, Porcaro MA, Mango T, et al. Active recent parvovirus B19 infection in children with Kawasaki disease. Lancet 1994;343:1260-1.
66. Yoto Y, Kudoh T, Haseyama K, Suzuki N, Chiba S, Matsunaga Y. Human parvovirus B19 infection in Kawasaki disease. Lancet 1994;344:58-9.
67. Leruez-Ville M, Laugé A, Morinet F, Guillevin L, Dény P. Polyarteritis nodosa and parvovirus B19. Lancet 1994;344:263-4.
68. Viguier M, Guillevin L, Laroche L. Treatment of parvovirus B19 associated polyarteritis nodosa with intravenous immune globulin. New Engl J Med 2001;344:1481-2.
69. Hansen KE, Arnason J, Bridges AJ. Autoantibodies and common viral illnesses. Semin Arthritis Rheum 1998;27:263-71.